{"id":212007,"name":"PFIZER","slug":"pfizer","state":"NY","country":"United States of America","description":"Pharmaceutical Company","totalSpending":1040000,"filings":19,"yearlySpending":[{"year":2021,"income":80000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":240000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["FEDERAL HEALTH POLICY STRATEGIES"],"lobbyists":["DAN ELLING","COOKAB HASHEMI","COLIN ROSKEY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to drug pricing","Drug pricing reform\nH.R. 3--Elijah E. Cummings Lower Drug Costs Now Act\nBiosimilar utilization policy\nS.912/H.R. 1978--the Protecting Seniors Through Immunization Act of 2021","Drug pricing reform\nH.R. 3--Elijah E. Cummings Lower Drug Costs Now Act\nBiosimilar utilization policy\nS.912/H.R. 1978--the Protecting Seniors Through Immunization Act of 2021\nH.R. 197--Federal Account","Drug pricing and coverage reforms H.R. 3--Elijah E. Cummings Lower Drug Costs Now Act--biosimilar utilization policy S. 912/H.R. 197 the Protecting Seniors Through Immunization Act of 2021 HR 1978--Pr","Drug pricing reform, H.R.3-Elijah E. Cummings Lower Drug Costs Now Act Biosimilar utilization policy S. 912/H.R. 197 S.91 the Protecting Seniors Through Immunization Act of 2021 HR 1978--Protecting Se"]}